UNTREATED ADULT ACUTE MYELOID LEUKEMIA
Clinical trials for UNTREATED ADULT ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new UNTREATED ADULT ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for UNTREATED ADULT ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for older AML patients
Disease control OngoingThis study tests whether adding the drug selinexor to standard chemotherapy can help older adults with untreated acute myeloid leukemia (AML) live longer and achieve remission. About 57 participants will receive either standard chemo alone or chemo plus selinexor, followed by mai…
Matched conditions: UNTREATED ADULT ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 26, 2026 07:57 UTC
-
Engineered t cells take aim at Hard-to-Treat leukemias
Disease control OngoingThis early-stage study tests a new type of immunotherapy for people with certain leukemias that have come back or not responded to standard treatment. The therapy uses a patient's own or donor's immune cells that are genetically modified to recognize and attack cancer cells carry…
Matched conditions: UNTREATED ADULT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 07:27 UTC